Eculizumab in Hypertensive Emergency-associated Hemolytic Uremic Syndrome — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Recruiting

Back to Hypertensive Emergency-associated Hemolytic Uremic Syndrome trials

Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.

Trial locations(1 site)

France

Tenon Hospital, Paris

Key details

Phase

Large-scale testing

Sponsor

Assistance Publique - Hôpitaux de Paris

Enrollment target

~66 participants

Started

November 2023

Primary completion

May 2026

Age range

18 Years and older

Last updated January 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov

Eculizumab in Hypertensive Emergency-associated Hemolytic Uremic Syndrome — Stella